Senior Management

Jae-Ouk Kim, Ph.D.

Jae-Ouk Kim, Ph.D., is the Senior Research Scientist of the Molecular Immunology Lab at IVI. In her current role, Dr. Kim is responsible for securing grants and overseeing research projects related to vaccine development and assessment of immunogenicity of vaccines. Her research interests also include identifying protective immune mechanisms against pathogens.

Dr. Kim has led various research projects as the principal investigator since 2010, including assessment of the maternal effect on immune responses to TB and respiratory syncytial virus (RSV) vaccine candidates in neonates, the role of NKT cell sensitization in RSV, effect of protein energy deficiency in mucosal immune responses using mice. She is also leading projects to develop a Shigella vaccine and Lassa fever mRNA vaccine, and to establish immunogenicity assessment of vaccines including pseudovirus neutralization system against highly pathogenic viruses including Ebola, Lassa, Nipah, MERS-CoV, SARS-CoV-2, and Crimean congo heamorrhagic virus, and more. The Molecular Immunology Lab also participated in collaborative studies to establish WHO international standard for immunoglobulin against MERS-CoV and SARS-CoV-2 by qualified ELISA and pseudovirus neutralization assay.

Dr. Kim graduated from the College of Pharmacy at Seoul National University (SNU) and continued her graduate studies at SNU, majoring in immunology. She then served as a postdoctoral fellow at the Vaccine Research Center/NIAID/NIH, USA before joining IVI in 2008.